"The February BC TALKS will feature five expert physicians: Prof. Stephen Johnston (UK), Dr. Carlos Barrios (BR), Dr. Shaheenah Dawood (UAE), Dr. Shigeharia Saji (JP) and Prof. Dr. Michael P. Lux (DE).
They will share data on the latest disclosures for abemaciclib for patients with HR+ HER2- breast cancer in the EBC and MBC setting and discuss the impact of this data in clinical practice.
• Share data on the latest disclosures for abemaciclib for patients with HR+ HER2-breast cancer in the EBC and MBC setting and discuss the impact of this data in clinical practice.
FREE
Free